# Tramadol Simultaneously With Sciatic Nerve Block for Calcaneus Fracture Osteosynthesis

> **NCT03477851** · PHASE4 · COMPLETED · sponsor: **Medical University of Warsaw** · enrollment: 40 (actual)

## Conditions studied

- Foot Fracture
- Pain, Acute

## Interventions

- **DRUG:** Tramadol Hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03477851
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-15
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03477851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03477851, "Tramadol Simultaneously With Sciatic Nerve Block for Calcaneus Fracture Osteosynthesis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03477851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*